期刊文献+

脑用表阿霉素壳聚糖微球的制备及其特性考察 被引量:9

Study on preparation and properties of epirubicin-loaded chitosan microspheres for the cerebral administration
下载PDF
导出
摘要 目的:以壳聚糖为载体材料,表阿霉素为模型药物,制备脑内局部给药缓释微球。方法:以液体石蜡为油相,L-抗坏血酸棕榈酸酯为交联剂,司盘-80为乳化剂,采用乳化化学交联技术制备表阿霉素脑用微球。用动态透析法研究微球的体外释放特性。结果:盐酸表阿霉素/壳聚糖的质量比为1∶9的载药微球形态良好,粒径分布较为均匀,平均粒径为(9.3±2.6)μm、载药量为(8.01±0.23)%、包封率为(72.9±2.2)%。体外释放具有良好的缓释效果。结论:所优化的制备工艺稳定,适用于脑用表阿霉素壳聚糖微球的制备。 OBJECTIVE To study the preparation technique and release characteristic of epirubicin-loaded chitosan microspheres for the cerebral administration. METHODS Using the liquid paraffin as oil phase,L-ascorbyl palmitate as cross linking agent,and span-80 as the emulsifier; epirubiein-loaded chitosan microspheres were achieved by emulsion-chemical cross link technique. Dynamic dialysis method was used to determine the releasing characteristic of microspheres in vitro. RESULTS Microspheres (epirubicin/chitosan 1: 9) with a good shape and narrow size distribution were prepared. The average diameter was (9. 3±2. 6)/μm. The ratio of drug loading was (8. 01 ± 0. 23)%. The ratio of entrapment was (72.9 ± 2.2)%. The drug release profile in vitro had a characteristic of good delayed release. CONCLUSION The optimized preparation technique is stable and has a high entrapment efficiency. So it could be used to prepare epirubicin-loaded chitosan microspheres for the cerebral administration.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2007年第2期148-152,共5页 Chinese Journal of Hospital Pharmacy
基金 浙江省教育厅科研基金资助项目(编号:20030805)
关键词 脑用 表阿霉素 壳聚糖 微球 cerebral administration epirubicin chitosan microspheres
  • 相关文献

参考文献8

  • 1Davson H,Segal MB.Physiology of the CSF and blood-brain barriers[M].Boca Raton:CRC Press,1996.
  • 2Brem H,Lawson HC.The development of new brain tumor therapy utilizing the local and sustained delivery of chemotherapeutic agents from biodegradable polymers[J].Cancer,1999,86(2):197-199.
  • 3Menei P,Venier MC,Gamelin E,et al.Local and sustained delivery of 5-fluorouracil from biodegradable microsphers for the radiosensitization of glioblastoma:a pliot study[J].Cancer,1999,86(2):325-330.
  • 4Francesca BM,Maria A R,Isabella O,et al.Controlled insulin release from chitosan microparticles[J].Arch Pharm Med Chem,1998,331.133-138.
  • 5方华丰,周宜开.壳聚糖微球的研究进展[J].国外医药(合成药.生化药.制剂分册),1999,20(5):315-319. 被引量:17
  • 6梁桂媛,方华丰,刘志伟.5-氟尿嘧啶壳聚糖微球的制备[J].广东药学院学报,2000,16(1):7-10. 被引量:23
  • 7石可瑜,李朝兴,何炳林.磁导向阿霉素-羧甲基葡聚糖磁性毫微粒的研究[J].生物医学工程学杂志,2000,17(1):21-24. 被引量:39
  • 8蒋新宇,周春山,邓晔.壳聚糖载药微球的研制[J].常德师范学院学报(自然科学版),2003,15(1):36-39. 被引量:11

二级参考文献16

  • 1程宇慧,廖工铁,侯世祥,李栗,张明.白蛋白微球作为肝靶向给药载体的研究[J].药学学报,1993,28(1):68-74. 被引量:20
  • 2吴传斌,魏树礼.磁性药物微球研究进展[J].中国药学杂志,1993,28(6):330-334. 被引量:27
  • 3王亚敏,石庭森,蒲永林,朱建纲,赵延乐.顺铂壳聚糖微球的制备及特性研究[J].药学学报,1996,31(4):300-305. 被引量:24
  • 4[3]Yamin W, Hitoshi S, Isao A, et al. Optimization of the Formulation Design of Chitosan Microspheres Containing Cisplatin[ J]. J Pharm Sci, 1996,85( 11 ): 1204 - 1210.
  • 5Gupta P K,Int J Pharm,1988年,43卷,167页
  • 6BoisdronCM,Menei P,Benoit JP. Preparation and Characterization of 5-fluorouracil-loadedmicroparticles as biodegradable anticancer drug carriers. J Pharm Pharmacol,1995,47(2):108.
  • 7Ciftci K,Hincal AA,Kas HS et al. Solid tumor chemotherapy and in vivo distributionof fluorouracil following administration in Poly (L-lactic acid)microspheres. Pharm DevTechnol,1997, 2(2):151.
  • 8Lisbeth I. Chitosan and its use as a pharmaceutical excipient. Pharm Res,1998,15(9):1326.
  • 9H Suheyl Kas. Chitosan:properties,preparations and application to microparticulatesystems. J Microencapsul,1997,14(6):689.
  • 10Sheu MT,Sokoloski TD. Entrapment of bioactive compounds within native albuminbeads:Ⅲ. Evaluation of parameters affecting drug release. J Parenter Sci Tec hnol,1986,40(6):259.

共引文献82

同被引文献156

引证文献9

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部